Study into conolidine has triggered discovery of an opioid receptor in the body identified as ACKR3/CXCR7. ACKR3 seems to be the most popular target for conolidine, which also disregards another 4 classical opioid receptors(3). Advancements in the comprehension of the cellular and molecular mechanisms of pain along with the https://optimusbookmarks.com/story20789383/details-fiction-and-conolidin-to-replace-traditional-painkillers